MedTrace Logo

Complementary and Integrative Pain Therapies and Functional Restoration (IMPPPORT) Trial)

NCT04656340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2024-12-24

No results posted yet for this study

Summary

This study aims to evaluate the benefit of a complementary and integrative health (CIH) pain management program when added to standard rehabilitative care (SC) compared to SC alone prior to an intensive functional restoration (FR) program in a population of active duty service members. In addition the study aims to identify factors that predict improvement in pain impact following treatment, and to determine the proportion of participants who experience clinically meaningful response.

SC included physical and occupational therapy. CIH included chiropractic, acupuncture, yoga and foam roller instruction. Both treatment groups also received education about pain psychology.

Participants were randomly assigned to a 3-week course of either SC alone or CIH combined with SC prior to a 3-week course of FR. Outcomes were collected at baseline, at end of stage 1, and post-FR. Outcomes included patient-reported and provider-determined measures.

Conditions

Interventions

OTHER

non-medication, non-interventional therapies

non-medication, non-interventional therapies

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED

  • University of Washington

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    collaborator OTHER

  • Madigan Army Medical Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-09
Primary Completion
2019-04-02
Completion
2019-04-02

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04656340 on ClinicalTrials.gov